The present invention relates to a pharmaceutical composition containing quinazoline derivatives or their salts thereof. More specifically, the present invention relates to a pharmaceutical composition containing 4-(3-chloro-4-(cyclopropylamino-carbonyl)aminophenoxy)-7-methoxy-6-quinoline carboxamide or its pharmacologically acceptable salt, and alkaline amino acids or meglumine, and/or at least one kind of compound selected from the group of potassium carbonate, potassium bicarbonate, and the said composition does not contain microcrystalline cellulose. The pharmaceutical composition has the characteristics of quick dissolution and good stability.本發明涉及一種含有喹啉衍生物或其鹽的醫藥組成物。具體而言,本發明涉及一種醫藥組成物,含有4-[3-氯-4-(環丙基胺基羰基)胺基苯氧基]-7-甲氧基-6-喹啉甲醯胺或其藥理學上可接受的鹽,以及鹼性胺基酸或葡甲胺,和/或選自碳酸鉀、碳酸氫鉀中的至少一種化合物;且所述的組成物中不含微晶纖維素。本發明的醫藥組成物具有溶出迅速、穩定性良好的特點。由於本案的圖為實驗數據,並非本案的代表圖。故本案無指定代表圖。
